Zhitong Finance App News, Changchun Hi-Tech (000661.SZ) issued an announcement. Recently, the company's holding subsidiary, Changchun Jinsai Pharmaceutical Co., Ltd. (hereinafter referred to as “Jinsai Pharmaceutical”) received the “Notice of Acceptance” approved and issued by the State Drug Administration, and Jinsai Pharmaceutical's domestically produced drug registration application for injectable GenSci136 was accepted.

Zhitong Finance App News, Changchun Hi-Tech (000661.SZ) issued an announcement. Recently, the company's holding subsidiary, Changchun Jinsai Pharmaceutical Co., Ltd. (hereinafter referred to as “Jinsai Pharmaceutical”) received the “Notice of Acceptance” approved and issued by the State Drug Administration, and Jinsai Pharmaceutical's domestically produced drug registration application for injectable GenSci136 was accepted.